Your browser doesn't support javascript.
loading
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
Gordon, Max J; Dubois, Sigrid; Bryant, Bonita; Ng, Samuel; Conlon, Kevin; Miljkovic, Milos D; Waldmann, Thomas; Roschewski, Mark.
Afiliação
  • Gordon MJ; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Dubois S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Bryant B; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Ng S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Conlon K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Miljkovic MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Waldmann T; Cartesian therapeutics, Gaithersburg, MD, USA.
  • Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Leuk Lymphoma ; 65(7): 1008-1011, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38459780

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T / Interleucina-15 / Anticorpos Monoclonais Humanizados Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T / Interleucina-15 / Anticorpos Monoclonais Humanizados Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article